Health Care & Life Sciences » Biotechnology | Scancell Holdings PLC

Scancell Holdings PLC

Scancell Holdings PLC
Stock Exchange London Stock Exchange
EPS
GBP1.53
Market Cap
GBP27.73 M
Shares Outstanding
465.36 M
Public Float
361.91 M

Profile

Address
John Eccles House
Oxford Oxfordshire OX4 4GP
United Kingdom
Employees -
Website http://scancell.co.uk
Updated 07/08/2019
Scancell Holdings Plc engages in the development of novel therapeutic vaccines for the treatment of cancer. It operates through ImmunoBody and Moditope technology platforms. The company was founded by Lindy Gillian Durrant in 1997 and is headquartered in Oxford, the United Kingdom.

Financials

View All

John C. Chiplin
Executive Chairman
Lindy Gillian Durrant
Executive Director & Chief Scientific Officer